Objective: to discuss and analyze the application and research of atomization inhalation therapy in pediatric respiratory diseases. Methods: from February 2019 to May 2020, 70 children with respiratory diseases were s...Objective: to discuss and analyze the application and research of atomization inhalation therapy in pediatric respiratory diseases. Methods: from February 2019 to May 2020, 70 children with respiratory diseases were selected as the research object. The 70 children were divided into two groups, A and B, with 35 children in each group. Patients in group A were given routine clinical medication, while patients in group B were given aerosol inhalation therapy. Finally, the therapeutic effects and the remission time of clinical symptoms of the two groups were compared. Results: after implementing the corresponding treatment measures in the two groups, it can be seen that the therapeutic effect of group B on children reached 96.24%, while that of group A only reached 79.23%. Comparing the data obtained from the two groups of children's therapeutic effects, it has statistical significance (P < 0.05). In addition, the time for the clinical symptoms of the two groups of children to disappear was significantly shorter in group B than in group A, and the two groups also had statistical significance (P < 0.05). After treatment, the data of blood oxygen saturation and maximal respiratory flow rate in group B were all better than those in group A, and the two groups also had statistical significance (P < 0.05). Conclusion: through this study, it can be seen that atomization inhalation therapy is more effective in the treatment of pediatric respiratory diseases, and it can also relieve various clinical symptoms of children in the shortest time. Atomization inhalation therapy is also safer in clinic, so it can be seen that atomization inhalation therapy is more effective.展开更多
文摘Objective: to discuss and analyze the application and research of atomization inhalation therapy in pediatric respiratory diseases. Methods: from February 2019 to May 2020, 70 children with respiratory diseases were selected as the research object. The 70 children were divided into two groups, A and B, with 35 children in each group. Patients in group A were given routine clinical medication, while patients in group B were given aerosol inhalation therapy. Finally, the therapeutic effects and the remission time of clinical symptoms of the two groups were compared. Results: after implementing the corresponding treatment measures in the two groups, it can be seen that the therapeutic effect of group B on children reached 96.24%, while that of group A only reached 79.23%. Comparing the data obtained from the two groups of children's therapeutic effects, it has statistical significance (P < 0.05). In addition, the time for the clinical symptoms of the two groups of children to disappear was significantly shorter in group B than in group A, and the two groups also had statistical significance (P < 0.05). After treatment, the data of blood oxygen saturation and maximal respiratory flow rate in group B were all better than those in group A, and the two groups also had statistical significance (P < 0.05). Conclusion: through this study, it can be seen that atomization inhalation therapy is more effective in the treatment of pediatric respiratory diseases, and it can also relieve various clinical symptoms of children in the shortest time. Atomization inhalation therapy is also safer in clinic, so it can be seen that atomization inhalation therapy is more effective.
